HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adams, A. S. Articles by Ross-Degnan, D. Search for Related Content PubMed Articles by Adams, A. S. Articles by Ross-Degnan, D. Social Bookmarking                What's this?

Race Differences in Long-Term Diabetes Management in an HMO

Response to Hart

¹ Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts
² General Medicine Unit, Massachusetts General Hospital, Boston, Massachusetts

Address correspondence to Dr. Alyce S. Adams, PhD, Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Ave., 6th Floor, Boston, MA 02215. E-mail: aadams@hms.harvard.edu

The first 20% of the full text of this article appears below.

We read Dr. Hart’s (1) response to our article with great interest. The issue of racial differences in the presence of variant hemoglobins that may affect HbA_1c (A1C) test results is certainly an important one. Ours (2) was a retrospective analysis using electronic medical record data that did not contain information on either the presence of sickle hemoglobin or the . . . [Full Text of this Article]

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. J. Wilkin Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT): Response to Bingley et al. Diabetes Care, April 1, 2008; 31(4): e29 - e29. [Full Text] [PDF]

				P. J. Bingley, J. L Mahon, E. A.M. Gale, and for the European Nicotinamide Diabetes Interventio Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT) Diabetes Care, January 1, 2008; 31(1): 146 - 150. [Abstract] [Full Text] [PDF]

				D. Dabelea and for the SEARCH for Diabetes in Youth Study Group Testing the Accelerator Hypothesis: Body Size, {beta}-Cell Function, and Age at Onset of Type 1 (Autoimmune) Diabetes: Response to Wilkin. Diabetes Care, June 1, 2006; 29(6): 1463 - 1464. [Full Text] [PDF]